Investors Land ACAD 6.0% Cheaper Than Its Secondary Stock Offering
August 11, 2016 at 10:11 AM EDT
Looking back to 2 days ago, Acadia Pharmaceuticals Inc (ACAD) priced a 6,060,606 share secondary stock offering at $33.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..